Neurophet and RapidAI Partner to Expand Access to Alzheimer's and MS Treatment Monitoring
- Written by PR Newswire
![]() |
- Agreement expands Neurophet's reach into U.S. health systems and builds on RapidAI's leadership in enterprise clinical AI and neurosciences
SEOUL, South Korea, Nov. 2, 2026 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, today announced a partnership with RapidAI, a global...
Read more: Neurophet and RapidAI Partner to Expand Access to Alzheimer's and MS Treatment Monitoring















